CABA Cabaletta Bio Inc
1,629
$11.26
$0.96
(7.86%)
| Watchers | 1,629 |
| 52-Wk Low | $9.02 |
| 52-Wk High | $26.35 |
| Market Cap | $527.02M |
| Volume | 859,505.00 |
| 52-Wk High | $26.35 |
| 52-Wk Low | $9.02 |
Citigroup Boosts Cabaletta Bio (NASDAQ:CABA) Price Target to $30.00Ticker Report • about 1 month ago
Cabaletta Bio (NASDAQ:CABA - Free Report) had its price objective lifted by Citigroup from $26.00 to $30.00 in a report published on Thursday morning, Benzinga reports. Citigroup currently has a buy...
Share to Feed
Cabaletta Bio (NASDAQ:CABA - Get Free Report) had its target price raised by stock analysts at Citigroup from $26.00 to $30.00 in a research note issued to investors on Thursday, Benzinga reports...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
For the last three days, A.I.dvisor has detected that CABA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
For the last three days, A.I.dvisor has detected that CABA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
For the last three days, A.I.dvisor has detected that CABA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Cabaletta Bio, Inc. (NASDAQ:CABA Free Report) William Blair issued their Q1 2024 earnings per share (EPS) estimates for Cabaletta Bio in a note issued to investors on Thursday...
For the last three days, A.I.dvisor has detected that CABA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Cabaletta Bio (NASDAQ:CABA Free Report) had its price target hoisted by HC Wainwright from $25.00 to $30.00 in a report released on Friday, Benzinga reports. The firm currently has a buy...
Cabaletta Bio (NASDAQ:CABA Free Report) had its target price raised by Wells Fargo Company from $34.00 to $35.00 in a report issued on Friday, Benzinga reports. The brokerage currently...